BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kusafuka K, Kawasaki T, Maeda M, Yamanegi K, Baba S, Ito Y, Inagaki H, Nakajima T. Salivary duct carcinoma with rhabdoid features: a salivary counterpart of pleomorphic lobular carcinoma of the breast. Histopathology 2017;70:164-73. [PMID: 27079821 DOI: 10.1111/his.12987] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Kusafuka K, Yamada H, Ishino K, Maeda M, Yamanegi K, Baba S, Ohuchi T, Inagaki H, Yamamoto H, Iwasaki T, Tsuchiya C, Sugimura H, Suzuki M. Salivary Duct Carcinoma With Rhabdoid Features-No or Aberrant Expression of E-cadherin and Genetic Changes in CDH1: Immunohistochemical and Genetic Analyses of 17 Cases. Am J Surg Pathol 2021;45:439-49. [PMID: 33538422 DOI: 10.1097/PAS.0000000000001672] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Haugaard CF, Agander TK, Lelkaitis G, Andersen KF, Andreasen S, Wessel I. Salivary gland carcinomas with unusual presentations. Acta Oncol 2019;58:382-4. [PMID: 30700203 DOI: 10.1080/0284186X.2019.1566768] [Reference Citation Analysis]
3 Silveira HA, Almeida LY, Nonaka CFW, Alves PM, Ribeiro-silva A, León JE. Myoepithelial carcinoma with rhabdoid features in the maxillary sinus: Immunohistochemical and in situ hybridization analysis of a rare case. Oral Oncology 2019;93:116-9. [DOI: 10.1016/j.oraloncology.2019.04.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
4 Egebjerg K, Harwood CD, Woller NC, Kristensen CA, Mau-Sørensen M. HER2 Positivity in Histological Subtypes of Salivary Gland Carcinoma: A Systematic Review and Meta-Analysis. Front Oncol 2021;11:693394. [PMID: 34249747 DOI: 10.3389/fonc.2021.693394] [Reference Citation Analysis]
5 Wasano K, Sakurai K, Kawasaki T, Kusafuka K, Kasahara M, Kondo N, Inada KI, Ogawa K. Acquisition of resistance to androgen deprivation therapy in salivary duct carcinoma: A case report. Rare Tumors 2018;10:2036361318798867. [PMID: 30263102 DOI: 10.1177/2036361318798867] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Nakaguro M, Tada Y, Faquin WC, Sadow PM, Wirth LJ, Nagao T. Salivary duct carcinoma: Updates in histology, cytology, molecular biology, and treatment. Cancer Cytopathol 2020;128:693-703. [PMID: 32421944 DOI: 10.1002/cncy.22288] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
7 Akaki M, Ishihara A, Nagai K, Naono H, Taguchi K, Yamamoto H, Tanaka H, Kataoka H. Signet Ring Cell Differentiation in Salivary Duct Carcinoma with Rhabdoid Features: Report of Three Cases and Literature Review. Head Neck Pathol 2021;15:341-51. [PMID: 32488734 DOI: 10.1007/s12105-020-01186-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Hsieh MS, Lee YH, Jin YT, Kuo YJ. Clinicopathological study of intraductal carcinoma of the salivary gland, with emphasis on the apocrine type. Virchows Arch 2020;477:581-92. [PMID: 32383006 DOI: 10.1007/s00428-020-02823-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
9 Rooper LM, Argyris PP, Thompson LDR, Gagan J, Westra WH, Jordan RC, Koutlas IG, Bishop JA. Salivary Mucinous Adenocarcinoma Is a Histologically Diverse Single Entity With Recurrent AKT1 E17K Mutations: Clinicopathologic and Molecular Characterization With Proposal for a Unified Classification. Am J Surg Pathol 2021. [PMID: 33739781 DOI: 10.1097/PAS.0000000000001688] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Kusafuka K, Kawasaki T, Onitsuka T, Hamaguchi N, Morita K, Mukaigawa T, Nishiya Y, Kamijo T, Iida Y, Nakajima T, Sugino T. Acantholytic Squamous Cell Carcinoma and Salivary Duct Carcinoma Ex-pleomorphic Adenoma of the Submandibular Gland: A Report of Two Extremely Rare Cases with an Immunohistochemical Analysis. Head Neck Pathol 2020;14:230-8. [PMID: 30484070 DOI: 10.1007/s12105-018-0987-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Rooper LM, Mansour M, Yonescu R, Oliai BR, Bishop JA, Westra WH. The Decline of Salivary Adenocarcinoma Not Otherwise Specified as a Tumor Entity: Reclassification Using Contemporary Immunohistochemical Profiling and Diagnostic Criteria. Am J Surg Pathol 2021;45:753-64. [PMID: 33284193 DOI: 10.1097/PAS.0000000000001636] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Rooper LM. Emerging Entities in Salivary Pathology: A Practical Review of Sclerosing Microcystic Adenocarcinoma, Microsecretory Adenocarcinoma, and Secretory Myoepithelial Carcinoma. Surg Pathol Clin 2021;14:137-50. [PMID: 33526218 DOI: 10.1016/j.path.2020.10.003] [Reference Citation Analysis]